1887

Abstract

SUMMARY

Encapsulation of purified tuberculoproteins in liposomes augmented their ability to elicit delayed hypersensitivity reactions in BCG-immune rats. The effect was most marked with a low-molecular-weight tuberculopeptide that was relatively poor at eliciting reactions when in free form. These findings indicate that, in addition to the antigenic nature of the material, the physical form of presentation of mycobacterial test antigens can influence their ability to elicit hypersensitivity reactions.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-18-3-429
1984-12-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/18/3/medmicro-18-3-429.html?itemId=/content/journal/jmm/10.1099/00222615-18-3-429&mimeType=html&fmt=ahah

References

  1. Burleson G. R., Kulpa C. F., de Matteis F. 1982; Old tuberculin associated with liposomes: A new interferon inducer.. Journal of Interferon Research 2:187–194
    [Google Scholar]
  2. Eppstein D. A. 1982; Altered pharmacologic properties of liposome-associated human interferon-alpha 2.. Journal of Interferon Research 2:117–125
    [Google Scholar]
  3. Fidler Raz A., Fogler W. E., Kirsh R., Bugelski P., Poste G. 1980; Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.. Cancer Research 40:4460–4466
    [Google Scholar]
  4. Gregoriadis G. 1976; The carrier potential of liposomes in biology and medicine. 2.. New England Journal of Medicine 295:704–710
    [Google Scholar]
  5. Gregordiadis G., Allison A. C. 1974; Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice.. Febs Letters 45:71–74
    [Google Scholar]
  6. Gupta K. C., Landi S. 1978; Isolation of tuberculin peptides from tuberculin purified protein derivative (PPD).. Canadian Journal of Microbiology 24:1242–1249
    [Google Scholar]
  7. Heath T. D., Edwards D. C., Ryman B. E. 1976; The adjuvant properties of liposomes.. Biochemical Society Transactions 4:129–133
    [Google Scholar]
  8. Kuwabara S. 1975; Purification and properties of tuberculin-active protein from Mycobacterium tuberculosis. Journal of Biological Chemistry 250:2556–2562
    [Google Scholar]
  9. Landi S., Held H. R. 1980; Preparation and characterization of a large batch of tuberculin purified protein derivative (PPD-CT68).. Annali Sclavo 22:899–907
    [Google Scholar]
  10. Landi S., Held H. R., Tseng M. C. 1970; Relationship between the molecular weight of tuberculoprotein and its biological potency.. Progress in Immunobiological Standardisation 4:512–520
    [Google Scholar]
  11. Pimm M. V., Baldwin R. W. 1984; Tumour models for screening immunomodulators: Suppression of tumour growth by delayed hypersensitivity reactions.. Behring Institute Mitteilungen. 74:214–218
    [Google Scholar]
  12. Pimm M. V., Embleton M. J., Perkins A. C., Price M. R., Robins R. A., Robinson G. R., Baldwin R. W. 1982; In vivo localization of anti-osteogenic sarcoma xenografts.. International Journal of Cancer 30:75–85
    [Google Scholar]
  13. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., Fidler I. J. 1982; Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.. Cancer Research 42:1412–1422
    [Google Scholar]
  14. Rosenthal S. R. 1980; Tuberculin sensitivity and BCG vaccination. In Rosenthal S. R. (ed) BCG vaccines: tuberculosis-cancer PSG Publishing Company Inc; Littleton, MA: pp 176–197
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-18-3-429
Loading
/content/journal/jmm/10.1099/00222615-18-3-429
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error